Implementation Guide CH VACD
5.0.0 - trial-use Switzerland flag

Implementation Guide CH VACD, published by HL7 Switzerland. This guide is not an authorized publication; it is the continuous build for version 5.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7ch/ch-vacd/ and changes regularly. See the Directory of published versions

Example Bundle: Test Case F 01: Add comment (note) to an existing Immunization

Document Details

Generated Narrative: Bundle Vaccination Record

Document Subject

Unable to resolve subject ''

Document Content

Vaccination Record

Id: RDC01-Composition

Identifier: urn:ietf:rfc:3986#urn:uuid:20609dba-9f6a-4b94-bafa-0bad6839bf67

Status: Final

Code: Immunization record (http://snomed.info/sct#41000179103)

Patient: Patient/TC-patient Wegmueller Monika

Date: December 8, 2021

Authors:

Patient/TC-patient Wegmueller Monika

Confidentiality: null Normal (qualifier value) (http://snomed.info/sct#17621005)

Sections:

Immunization Administration

Immunization Administration

Code: Hx of Immunization (http://loinc.org#11369-6)

Entries:

Immunization/TCF01-IMMUN3

Additional Resources Included in Document

Entry 1 - fullUrl = http://test.fhir.ch/r4/Composition/RDF01-Composition

Resource Composition:

Vaccination Record

Id: RDC01-Composition

Identifier: urn:ietf:rfc:3986#urn:uuid:20609dba-9f6a-4b94-bafa-0bad6839bf67

Status: Final

Code: Immunization record (http://snomed.info/sct#41000179103)

Patient: Patient/TC-patient Wegmueller Monika

Date: December 8, 2021

Authors:

Patient/TC-patient Wegmueller Monika

Confidentiality: null Normal (qualifier value) (http://snomed.info/sct#17621005)

Sections:

Immunization Administration

Entry 2 - fullUrl = http://test.fhir.ch/r4/Patient/TC-patient

Resource Patient:

Generated Narrative: Patient TC-patient

Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)

Contact Detail
  • ph: tel:+41.32.685.12.34(Home)
  • Leidensweg 10 Specimendorf 9876 CH

Entry 3 - fullUrl = http://test.fhir.ch/r4/Practitioner/TC-HCP1-C1

Resource Practitioner:

Generated Narrative: Practitioner TC-HCP1-C1

identifier: GLN/7601888888884

active: true

name: Peter Müller

telecom: ph: tel:+41.32.234.55.66(Work), fax: fax:+41.32.234.55.67(Work), mailto:allzeit.bereit@gruppenpraxis.ch, http://www.gruppenpraxis.ch

address: Grabenstrasse 2 Zürich 8005 CH

Entry 4 - fullUrl = http://test.fhir.ch/r4/Organization/TC-ORG1

Resource Organization:

Generated Narrative: Organization TC-ORG1

identifier: GLN/7601777777718

name: Gruppenpraxis Müller

contact

telecom: ph: tel:+41.32.234.55.66(Work), fax: fax:+41.32.234.55.67(Work), mailto:bereit@gruppenpraxis.ch, http://www.gruppenpraxis.ch

address: Grabenstrasse 2 Zürich ZH 8005 CH

Entry 5 - fullUrl = http://test.fhir.ch/r4/PractitionerRole/TC-HCP1-ORG1-ROLE-performer

Resource PractitionerRole:

Generated Narrative: PractitionerRole TC-HCP1-ORG1-ROLE-performer

active: true

practitioner: Practitioner Peter Müller

organization: Organization Gruppenpraxis Müller

Entry 6 - fullUrl = http://test.fhir.ch/r4/Immunization/TCF01-IMMUN3

Resource Immunization:

Generated Narrative: Immunization TCF01-IMMUN3

Author of the content: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)

CH VACD Extension Immunization Medication Reference: Medication HAVRIX 1440 Inj Susp

identifier: urn:oid:2.16.756.5.30.1.402.1.3.1.1.1/94bdf3b1-0c04-42d3-9901-7e68f124f5ff

status: Completed

vaccineCode: Havrix 1440

lotNumber: AHAVB946A

patient: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)

occurrence: 2021-05-27

route: Intramuscular use

Performers

-Actor
*PractitionerRole

note: Der Patient hat diese Impfung ohne jegliche Nebenwirkungen gut vertragen. (By Practitioner/TC-HCP1-C1 @2021-06-02)

ProtocolApplieds

-TargetDisease
*Viral hepatitis, type A (disorder)

Entry 7 - fullUrl = http://test.fhir.ch/r4/Medication/TC-IMMUN-MEDIC-HAVRIX1440

Resource Medication:

Generated Narrative: Medication TC-IMMUN-MEDIC-HAVRIX1440

identifier: urn:oid:2.16.756.5.30.1.402.1.3.1.1.1/359000dc-2cee-4a6e-ab05-577f558840e2

code: HAVRIX 1440 Inj Susp

status: Active

ingredient

Batches

-LotNumber
*AHAVB946A

Entry 8 - fullUrl = http://test.fhir.ch/r4/Organization/TC-ORG-GSK

Resource Organization:

Generated Narrative: Organization TC-ORG-GSK

identifier: GLN/7601001000674

name: GlaxoSmithKline AG

contact

telecom: ph: tel:+41 31 862 21 11(Work), fax: fax:+41 31 862 22 00(Work), mailto:swiss.info@gsk.com, https://www.gsk.com

address: Talstrasse 3-5 Münchenbuchsee BE 3053 CH